Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1)
- 2 December 2008
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 26 (51), 6550-6554
- https://doi.org/10.1016/j.vaccine.2008.09.050
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Update on Avian Influenza A (H5N1) Virus Infection in HumansThe New England Journal of Medicine, 2008
- Enhanced growth of seed viruses for H5N1 influenza vaccinesVirology, 2007
- Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trialThe Lancet, 2007
- Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trialThe Lancet, 2006
- Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality systemVaccine, 2005
- Characterisation of the Protein Content of a Meningococcal Outer Membrane Vesicle Vaccine by Polyacrylamide Gel Electrophoresis and Mass SpectrometryHuman Vaccines, 2005
- Evaluation of a Genetically Modified Reassortant H5N1 Influenza A Virus Vaccine Candidate Generated by Plasmid-Based Reverse GeneticsVirology, 2003
- Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shapeThe EMBO Journal, 1997
- An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccinesJournal of Biological Standardization, 1977